+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Global Neuroprosthetics Market - Forecasts from 2022 to 2027

  • PDF Icon

    Report

  • 130 Pages
  • April 2022
  • Region: Global
  • Knowledge Sourcing Intelligence LLP
  • ID: 5602511
Neuroprosthetics are devices that are implanted in patients having neural damage to compensate for and restore the normal functioning of the nerves, which consequently help in partially restoring normal bodily functions. The rising incidences of neurological disorders worldwide is one of the major factors anticipated to boost the growth of the global neuroprosthetics market during the forecast period. Furthermore, the growing number of diabetes patients, leading to nerve damage in many people, is also expected to lead to a surge in demand for neuroprosthetics in the coming years. Moreover, the number of people with disabling hearing loss has been increasing substantially over the years, and its projected rapid rise in the coming years is further anticipated to augment the growth of the global neuroprosthetics market during the assessment period.



The COVID-19 pandemic had a negative impact on the global neuroprosthetics market as access to healthcare was limited for non-COVID patients during the peak of the coronavirus outbreak. The focus of the healthcare system was shifted to COVID-19 patients due to a huge number of mortalities. This led to a decrease in the diagnosis and treatment of patients with disabling hearing loss, neurological disorders, and patients with other conditions requiring the use of neuroprosthetics. This led to a decrease in the demand for neuroprosthetics during the pandemic, which resulted in a decline in the market growth in 2020.

Rising cases of neurological disorders


The number of people suffering from neurological disorders is on the rise worldwide and is one of the prominent reasons anticipated to drive the demand for neuroprosthetics during the forecast period. According to World Health Organization, the number of deaths caused by neurological disorders has increased by nearly 39% in the last 30 years. It has also been stated that an increase in the number of patients with neurological disorders is being seen over the years, while the number of cases is further projected to grow in the coming years owing to a growing elderly population, a decrease in child mortality, and rise in the survival rate and life expectancy. As per data from the PAHO, the years lived with disability (YLDs) per 100,000 population in Brazil has increased from 784.06 years in 2010 to 813.74 years in 2019. In Mexico, it increased from 721.78 years in 2010 to 737.02 years in 2019. In the United States, the deaths from neurological disorders increased from 39.29 deaths per 100,000 population in 2010 to 47.39 deaths in 2019, witnessing an increase of more than 20%. The diseases such as Alzheimer's, dementia, and Parkinson’s disease are some of the neurological disorders spreading fast. For instance, as per Pan America Health Organization, Canada has witnessed a surge in the disability-adjusted life years (DALYs) per 100,000 population from 351.30 in 2010 to 415.70 in 2019, growing by more than 18%.

Growing prevalence of hearing loss


As neuroprosthetics are used in severe hearing loss, the increasing prevalence of hearing loss worldwide is a significant factor expected to augment the growth of the global neuroprosthetics market in the coming years. According to data from the WHO, the absolute number of people with hearing loss in Brazil has increased from 10 million in 2008 to 13 million in 2018. In China, the number has increased from 74 million in 2008 to 96 million in 2018, while in India, the number of people with hearing loss increased from 76.5 million in 2008 to 100 million in 2018. WHO has projected that people with disabling hearing loss will increase from 430 million in 2020 to more than 700 million by 2050. This is expected to surge the demand for neuroprosthetics significantly.

North America projected to have a major market share


Geographically, the North American region is anticipated to hold a significant market share owing to the rising cases of neurological disorders in the region, especially in the United States. Furthermore, the presence of a quality healthcare system and its accessibility to the patients makes the diagnosis and treatment stronger, which is another prominent reason for the large market size of neuroprosthetics in the region. The Asia Pacific region is anticipated to witness substantial growth due to the rising prevalence of hearing loss in the region. According to data from the WHO, the absolute number of people with disabling hearing loss in South Asia is projected to increase from 131 million in 2018 to 176 million in 2030 and further to 267 million in 2050. Furthermore, the rapidly growing cases of diabetes in the region are leading to damage to the nerves and blood vessels of a large number of patients, which is further projected to surge the demand for neuroprosthetics in the Asia Pacific region during the assessment period.

Segmentation


By Type

  • Output Neural Prosthetics
  • Input Neural Prosthetics

By Technique

  • Deep Brain Stimulation
  • Spinal Cord Stimulation
  • Sacral Nerve Stimulation
  • Transcranial Magnetic Stimulation
  • Vague Nerve Stimulation

By Application

  • Auditory Processing Disorders
  • Parkison’s Disease
  • Epilepsy
  • Ophthalmic Disease
  • Cardiovascular Disease
  • Paralysis
  • Alzheimer's Disease
  • Others

By Geography

  • North America
  • USA
  • Canada
  • Mexico
  • South America
  • Brazil
  • Argentina
  • Others
  • Europe
  • Germany
  • France
  • UK
  • Others
  • Middle East and Africa
  • Saudi Arabia
  • UAE
  • Others
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Taiwan
  • Thailand
  • Indonesia
  • Others

Table of Contents

1. Introduction
1.1. Market Definition
1.2. Market Segmentation
2. Research Methodology
2.1. Research Data
2.2. Assumptions
3. Executive Summary
3.1. Research Highlights
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porter's Five Forces Analysis
4.3.1. Bargaining Power of End-Users
4.3.2. Bargaining Power of Buyers
4.3.3. Threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
5. Global Neuroprosthetics Market Analysis, by Type
5.1. Introduction
5.2. Output Neural Prosthetics
5.3. Input Neural Prosthetics
6. Global Neuroprosthetics Market Analysis, by Technique
6.1. Introduction
6.2. Deep Brain Stimulation
6.3. Spinal Cord Stimulation
6.4. Sacral Nerve Stimulation
6.5. Transcranial Magnetic Stimulation
6.6. Vague Nerve Stimulation
7. Global Neuroprosthetics Market Analysis, by Application
7.1. Introduction
7.2. Auditory Processing Disorders
7.3. Parkison’s Disease
7.4. Epilepsy
7.5. Ophthalmic Disease
7.6. Cardiovascular Disease
7.7. Paralysis
7.8. Alzheimer's Disease
7.9. Others
8. Global Neuroprosthetics Market Analysis, by Geography
8.1. Introduction
8.2. North America
8.2.1. USA
8.2.2. Canada
8.2.3. Mexico
8.3. South America
8.3.1. Brazil
8.3.2. Argentina
8.3.3. Others
8.4. Europe
8.4.1. Germany
8.4.2. France
8.4.3. UK
8.4.4. Others
8.5. Middle East and Africa
8.5.1. Saudi Arabia
8.5.2. UAE
8.5.3. Others
8.6. Asia Pacific
8.6.1. China
8.6.2. India
8.6.3. Japan
8.6.4. South Korea
8.6.5. Taiwan
8.6.6. Thailand
8.6.7. Indonesia
8.6.8. Others
9. Competitive Environment and Analysis
9.1. Major Players and Strategy Analysis
9.2. Emerging Players and Market Lucrativeness
9.3. Mergers, Acquisitions, Agreements, and Collaborations
9.4. Vendor Competitiveness Matrix
10. Company Profiles
10.1. SenArs
10.2. LivaNova PLC
10.3. Medtronic PLC
10.4. Sonova Holding AG
10.5. Boston Scientific Corporation
10.6. Cochlear Ltd
10.7. Demant AS
10.8. Abbott Laboratories
10.9. NeuroPace, Inc.
10.10. BrainGate
10.11. NDI Medica

Companies Mentioned

  • SenArs
  • LivaNova PLC
  • Medtronic PLC
  • Sonova Holding AG
  • Boston Scientific Corporation
  • Cochlear Ltd
  • Demant AS
  • Abbott Laboratories
  • NeuroPace, Inc.
  • BrainGate
  • NDI Medica